XML 14 R1.htm IDEA: XBRL DOCUMENT v3.20.2
Document and Entity Information - shares
 9 Months Ended
Sep. 30, 2020
Nov. 11, 2020
Document Type 10-Q  
Document Period End Date Sep. 30, 2020  
Current Fiscal Year End Date --12-31  
Document Fiscal Year Focus 2020  
Document Fiscal Period Focus Q3  
Entity Registrant Name Cyclacel Pharmaceuticals, Inc.  
Entity Central Index Key 0001130166  
Amendment Flag false  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   4,863,984
Common Stock [Member]    
Title of 12(b) Security Common Stock, par value $0.001 per share  
Trading Symbol CYCC  
Security Exchange Name NASDAQ  
Preferred Stock [Member]    
Title of 12(b) Security Preferred Stock, $0.001 par value  
Trading Symbol CYCCP  
Security Exchange Name NASDAQ